Back to results
US 2026/0083753 A1Published application
Compositions for the Treatment of Metabolic Syndrome and Other Metabolic Disorders, and Methods of Manufacture
AssigneeFlorida Research Group LLC
InventorKotha SEKHARAM
Life of this patent
Estimating the term…
Abstract
The subject invention provides improved compositions for metabolic syndrome and methods of preparing the compositions via, for example, hot-melt extrusion. The resulting extrudate has improved solubility, bioavailability and therapeutic effect for treatment of metabolic syndrome at a low dose.
Claims25
A method for preparing a composition for the treatment of a metabolic disorder, wherein the method comprises:
- (i) blending (a) one or more of 3β-hydroxyurs-12-en-28-oic acid (UA), 3β-hydroxyolean-12-en-28-oic acid (OA), and salts thereof with (b) at least one modulator extract selected from the group consisting of piperine, capsaicin, and gingerol, and (c) a water-soluble polymer having a glass transition temperature lower than 170° C.;
- (ii) melt extruding the blend at a temperature about 60° C. to about 180° C. to obtain an extrusion product;
- (iii) grinding and mixing the extrusion product with a carrier or excipient to produce the composition.
A pharmaceutical composition comprising:
- (a) at least one of the following:
- UA, an isomer, or a salt thereof;
- and
- OA, an isomer or a salt thereof;
- (b) at least one modulator extract selected from the group consisting of piperine, capsaicin, and gingerol;
- (c) a water-soluble polymer having a glass transition temperature lower than 170° C.;
- and
- (d) a pharmaceutically acceptable carrier.
5 more elements
Dependencies are inferred from the claim text.